Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease

  • Myriam Amsallem
  • David Boulate
  • Zoe Kooreman
  • Roham T. Zamanian
  • Guillaume Fadel
  • Ingela Schnittger
  • Elie Fadel
  • Michael V. McConnell
  • Gundeep Dhillon
  • Olaf Mercier
  • François Haddad
Original Paper

Abstract

This study determined whether novel right heart echocardiography metrics help to detect pulmonary hypertension (PH) in patients with advanced lung disease (ALD). We reviewed echocardiography and catheterization data of 192 patients from the Stanford ALD registry and echocardiograms of 50 healthy controls. Accuracy of echocardiographic right heart metrics to detect PH was assessed using logistic regression and area under the ROC curves (AUC) analysis. Patients were divided into a derivation (n = 92) and validation cohort (n = 100). Experimental validation was assessed in a piglet model of mild PH followed longitudinally. Tricuspid regurgitation (TR) was not interpretable in 52% of patients. In the derivation cohort, right atrial maximal volume index (RAVI), ventricular end-systolic area index (RVESAI), free-wall longitudinal strain and tricuspid annular plane systolic excursion (TAPSE) differentiated patients with and without PH; 20% of patients without PH had moderate to severe RV enlargement by RVESAI. On multivariate analysis, RAVI and TAPSE were independently associated with PH (AUC = 0.77, p < 0.001), which was confirmed in the validation cohort (0.78, p < 0.001). Presence of right heart metrics abnormalities did not improve detection of PH in patients with interpretable TR (p > 0.05) and provided moderate detection value in patients without TR. Only two patients with more severe PH (mean pulmonary pressure 35 and 36 mmHg) were missed. The animal model confirmed that right heart enlargement discriminated best pigs with PH from shams. This study highlights the frequency of right heart enlargement and dysfunction in ALD irrespectively from presence of PH, therefore limiting their use for detection of PH.

Keywords

Echocardiography Lung disease Pulmonary hypertension Right heart failure Strain 

Notes

Acknowledgements

The authors would like to thank the Stanford Cardiovascular Institute and Vera Moulton Wall Center of Pulmonary Hypertension at Stanford for their support.

Funding

This study was funded by the Stanford Cardiovascular Institute, the Vera Moulton Wall Center of Pulmonary Hypertension at Stanford and the French National Reseach Agency (ANR-15-RHUS-0002).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest. MA received a Young Investigator Seed Grant from the Vera Moulton Wall Center. MVM previously received cardiac MRI research support from GE Healthcare and is currently on partial leave of absence while at Verily. FH received funds from Pai Chan Lee Research fund.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed (Institutional Animal Care Committee of Marie Lannelongue Hospital, Paris-Sud University, France). All procedures performed in studies involving human participants were approved by Stanford University Institutional Review Board in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Supplementary material

10554_2017_1069_MOESM1_ESM.pdf (898 kb)
Supplementary material 1 (PDF 897 KB)
10554_2017_1069_MOESM2_ESM.pdf (79 kb)
Supplementary material 2 (PDF 79 KB)
10554_2017_1069_MOESM3_ESM.pdf (313 kb)
Supplementary material 3 (PDF 313 KB)

References

  1. 1.
    Galiè N, Humbert M, Vachiery J-L, Gibbs S, et al. (2015) ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 46:903–975.CrossRefPubMedGoogle Scholar
  2. 2.
    Fisher MR, Criner GJ, Fishman AP et al (2007) Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 30:914–921CrossRefPubMedGoogle Scholar
  3. 3.
    Nathan SD, Shlobin OA, Barnett SD et al (2008) Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 102:1305–1310CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Amsallem M, Sternbach JM, Adigopula S et al (2015) Addressing the controversy of estimating pulmonary arterial pressure by echocardiography. J Am Soc Echocardiogr 29:93–102CrossRefPubMedGoogle Scholar
  5. 5.
    Raymond RJ, Hinderliter AL, Willis PW et al (2002) Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39:1214–1219CrossRefPubMedGoogle Scholar
  6. 6.
    Ghio S, Klersy C, Magrini G et al (2010) Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 140:272–278CrossRefPubMedGoogle Scholar
  7. 7.
    Vonk Noordegraaf A, Galiè N (2011) The role of the right ventricle in pulmonary arterial hypertension. Eur Respir Rev 20:243–253CrossRefPubMedGoogle Scholar
  8. 8.
    Zimbarra Cabrita I, Ruísanchez C, Grapsa J et al (2013) Validation of the isovolumetric relaxation time for the estimation of pulmonary systolic arterial blood pressure in chronic pulmonary hypertension. Eur Heart J Cardiovasc Imaging 14:51–55CrossRefPubMedGoogle Scholar
  9. 9.
    Hilde JM, Skjørten I, Grøtta OJ et al (2013) Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol 62:1103–1111CrossRefPubMedGoogle Scholar
  10. 10.
    McLaughlin VV, Archer SL, Badesch DB et al (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 119:2250–2294CrossRefPubMedGoogle Scholar
  11. 11.
    Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:685–788CrossRefPubMedGoogle Scholar
  12. 12.
    Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39CrossRefPubMedGoogle Scholar
  13. 13.
    Mercier O, Fadel E (2013) Chronic thromboembolic pulmonary hypertension: animal models. Eur Respir J 41:1200–1206CrossRefPubMedGoogle Scholar
  14. 14.
    Guihaire J, Haddad F, Boulate D et al (2014) Right ventricular plasticity in a porcine model of chronic pressure overload. J Heart Lung Transplant 33:194–202CrossRefPubMedGoogle Scholar
  15. 15.
    Jurcut R, Giusca S, La Gerche A et al (2010) The echocardiographic assessment of the right ventricle: what to do in 2010? Eur J Echocardiogr 11:81–96CrossRefPubMedGoogle Scholar
  16. 16.
    Hilde JM, Skjørten I, Hansteen V et al (2016) Assessment of right ventricular afterload in COPD. COPD 13:176–185CrossRefPubMedGoogle Scholar
  17. 17.
    Bréchot N, Gambotti L, Lafitte S et al (2008) Usefulness of right ventricular isovolumic relaxation time in predicting systolic pulmonary artery pressure. Eur J Echocardiogr 9:547–554CrossRefPubMedGoogle Scholar
  18. 18.
    Dambrauskaite V, Delcroix M, Claus P et al (2005) The evaluation of pulmonary hypertension using right ventricular myocardial isovolumic relaxation time. J Am Soc Echocardiogr 18:1113–1120CrossRefPubMedGoogle Scholar
  19. 19.
    Fukuda Y, Tanaka H, Sugiyama D et al (2011) Utility of right ventricular free wall speckle-tracking strain for evaluation of right ventricular performance in patients with pulmonary hypertension. J Am Soc Echocardiogr 24:1101–1108CrossRefPubMedGoogle Scholar
  20. 20.
    Utsunomiya H, Nakatani S, Okada T et al (2011) A simple method to predict impaired right ventricular performance and disease severity in chronic pulmonary hypertension using strain rate imaging. Int J Cardiol 147:88–94CrossRefPubMedGoogle Scholar
  21. 21.
    Rice JL, Stream AR, Fox DL et al (2016) Speckle tracking echocardiography to evaluate for pulmonary hypertension in chronic obstructive pulmonary disease. COPD 13:1–6CrossRefGoogle Scholar
  22. 22.
    Greiner S, Jud A, Aurich M, et al. (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Haddad F, Fadel E (2014) RV dysfunction after lung transplantation: a new prognostic marker or mainly a correlate of lung allograft function? JACC Cardiovasc Imaging 7:1095–1097CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2017

Authors and Affiliations

  • Myriam Amsallem
    • 1
    • 5
  • David Boulate
    • 2
  • Zoe Kooreman
    • 1
  • Roham T. Zamanian
    • 3
    • 4
  • Guillaume Fadel
    • 1
  • Ingela Schnittger
    • 1
  • Elie Fadel
    • 2
  • Michael V. McConnell
    • 1
  • Gundeep Dhillon
    • 3
  • Olaf Mercier
    • 2
  • François Haddad
    • 1
  1. 1.Division of Cardiovascular MedicineStanford University School of MedicineStanfordUSA
  2. 2.Laboratoire de Recherche Chirurgicale, Marie Lannelongue HospitalUniversity of Paris SudLe Plessis RobinsonFrance
  3. 3.Division of Pulmonary and Critical Care MedicineStanford University School of MedicineStanfordUSA
  4. 4.Vera Moulton Wall Center for Pulmonary Vascular DiseaseStanford University School of MedicineStanfordUSA
  5. 5.Stanford Cardiovascular InstituteStanfordUSA

Personalised recommendations